Related by context. All words. (Click for frequent words.) 67 Romark 66 Robert L. Bratzler 66 Paul Laikind 65 Alton Boynton 64 Amarantus 64 Christoph Westphal MD Ph.D. 64 Etubics 63 Iris Loew Friedrich 63 Barry D. Quart 63 Zyngenia 63 Eric L. Dobmeier 63 Tod Woolf 62 Kevin Rakin 62 Ron Bentsur Chief Executive 62 stated Michelle Berrey 62 Anthony J. Armini 62 Jeffrey M. Ostrove 62 Dr. Jaap Goudsmit 62 Dino Dina 62 Ron Bentsur 62 Ulrich Dauer CEO 61 Kirsten Drejer 61 Howard H. Pien 61 Kazumi Shiosaki 61 Alan Kessman Chief Executive 61 Mohammad Azab MD 61 stated Avtar Dhillon 61 HDL Selective Delipidation 61 CCR5 mAb 61 Neogenix 61 Dr. Arndt Schottelius 61 Harry Palmin President 61 Dr. Boro Dropulic 61 Georges Gemayel 61 Sudhir Agrawal D.Phil 60 Dan Passeri Curis 60 Addrenex Pharmaceuticals 60 Spiro Rombotis President 60 Vantia Therapeutics 60 Progenics Founder 60 Mitchel Sayare 60 Norbert Bischofberger 60 KaloBios 60 Dr. Wayne Danter 60 Maxine Gowen Ph.D. 60 Nicole Onetto MD 60 Immunotherapeutic 60 Cancer Immunobiology Center 60 Prabhavathi Fernandes 60 Eric von Hofe 60 EnVivo 60 Michael Boyce Jacino 60 Barry Selick 60 Monoclonal antibody 60 Nicholas Nicolaides 60 Mark Pykett 60 Dr Bernd Hentsch 60 Phase 1b clinical trials 60 Dr. Fahar Merchant 60 Mark A. Sirgo 60 ThromboGenics commenting 60 Reports Preclinical Data 60 Mihael Polymeropoulos MD 60 Dr. Aiping Young 60 therapeutic monoclonal antibody 60 ImmunoCellular Therapeutics 60 Tod Woolf Ph.D. 60 Michael V. Novinski 60 stated Belinda Tsao 60 Syndax 59 George J. Vergis 59 Daniel Von Hoff 59 David Schenkein MD 59 Alan Kingsman 59 Uli Hacksell Ph.D. 59 Ben Slotman 59 VentiRx 59 Nancy Simonian MD 59 Adelene Q. Perkins 59 Neil K. Warma 59 Dr. Marlies Sproll 59 Omacetaxine 59 preclinically 59 Mark Leuchtenberger 59 MGd 59 CEQ# 59 Profectus BioSciences 59 4SC commented 59 Ph.D. Targacept 59 Patrik De Haes 59 Michel Morre DVM 59 Chronogen 59 June Almenoff MD 59 THR beta agonist 59 Ira L. Goldknopf 59 Daniel Junius 59 Aflibercept 59 Bernd R. Seizinger 59 David Aviezer 59 Jose Baselga 59 Christian Itin 59 SIX RO ROG 58 GVAX ® 58 Elazar Rabbani 58 Steven B. Ratoff 58 UTHSCSA 58 Enobia 58 Cardioxyl 58 David Sidransky 58 Bassil Dahiyat Ph.D. 58 Enanta Pharmaceuticals 58 JAK1 58 Haim Aviv 58 MD Geron 58 BioNumerik 58 Barry Selick Threshold 58 Armando Anido Chief Executive 58 Vincent Mutel CEO 58 ProMune 58 JJ Finkelstein 58 Eric Rowinsky MD 58 Mads Krogsgaard Thomsen 58 Dr. Masamichi Koike 58 immatics 58 Genetic Therapy 58 EnVivo Pharmaceuticals 58 Kathy Ordoñez Chief Executive 58 Corixa Corporation 58 Marillion Pharmaceuticals 58 Thomas Ramdahl 58 Thiovir 58 oral picoplatin 58 DiscoveryBioMed 58 TIMI Study Group 58 Dr. Ruoslahti 58 Raymond F. Schinazi 58 Exosome 58 Dr. Michelle Berrey 58 Mr. Zami Aberman 58 Cempra Pharmaceuticals 58 Rosty Raykov Chief Executive 58 targeting CD# 58 orally administered inhibitor 58 Haro Hartounian Ph.D. 58 Blum Cytokinetics 58 Philippe Archinard Chief Executive 58 Semafore 58 DCVax R 58 Panzem R 58 ProNAi 58 Celator 58 Staph Leavenworth Bakali 58 Ph.D. XenoPort 58 Zosano Pharma 57 DNA methyltransferase inhibitors 57 Chemokine Therapeutics 57 Tuan Ha Ngoc 57 Curaxin 57 t2cure GmbH 57 Per Olof Wallström 57 Jorge Cortes MD 57 ENMD # 57 Laurence Birch DATATRAK 57 Zheng Cui 57 Tragara Pharmaceuticals Inc. 57 James Sapirstein 57 kidney urologic 57 hyaluronidase enzyme 57 Philippe Archinard 57 Wellstat 57 Eureka Genomics 57 MAGE A3 ASCI 57 Preclinical Development 57 Antisense Pharma 57 Diatos 57 selective orally bioavailable 57 Mr. Yves Rosconi 57 INSPIRE Trial Phase III 57 Dr. Ihor Gussak 57 Patrice Milos 57 Mr. Frank Menzler 57 Dr. Philip Toleikis 57 Greg Wujek 57 Prima BioMed 57 multicenter Phase II 57 enGene 57 Eckard Weber 57 Malcolm Skolnick CytoGenix 57 immunotoxins 57 Juergen Engel 57 Trellis Bioscience 57 KNS # 57 Cascade LifeSciences 57 NPC 1C 57 Kenneth Kornman 57 Dr. Amnon Gonenne 57 Spiro Rombotis 57 REGENERX BIOPHARMACEUTICALS INC. 57 brivanib 57 Bob Baltera Chief Executive 57 Trophos 57 Hans Clevers 57 Lucie Bruijn 57 LT NS# 57 Intarcia 57 Ray Salemme 57 forodesine 57 Alvine Pharmaceuticals 57 Creabilis Therapeutics 57 Mark Leuchtenberger President 57 Tesmilifene 57 ProLindac TM 57 M.D. Ph.D. 57 FoldRx Pharmaceuticals Inc. 57 Howard Fillit MD 57 John R. Plachetka 57 OPi 57 Friedhelm Blobel 57 SIgN 57 James Manuso 57 CALGB 57 HuLuc# 56 Ralph Makar 56 CYT# potent vascular disrupting 56 Kuslima Shogen 56 ViroStatics 56 Hedgehog antagonist 56 NEUGENE 56 Phase IIb clinical trials 56 Elisabeth Lindner CEO 56 Bellicum 56 Antibody Discovery 56 Zami Aberman Pluristem 56 YONDELIS R 56 Plasticell 56 Klaus Schollmeier Chief Executive 56 Euroscreen 56 Bafetinib 56 receptor tyrosine kinase inhibitor 56 VIRxSYS 56 Pervasis 56 radiation sensitizer 56 ActivX 56 David Moskowitz GenoMed 56 Immunex Corporation 56 Developmental Therapeutics 56 Charlotte Keywood 56 Phase #b/#a clinical 56 Lars Kongsbak 56 Tectin TM 56 Affimed Therapeutics AG 56 Per Olof Andersson 56 TargeGen 56 Allovectin 7 56 Anthony Giovinazzo 56 ImmuneRegen 56 MicuRx 56 Shai N. Gozani 56 Epiphany Biosciences 56 Harold Van Wart 56 Initiates Clinical 56 MBRX 56 molecular virology 56 Inovio Pharmaceuticals 56 Demetrius Pohl 56 Liquid Tissue 56 Jim Sulat 56 DermaVir Patch 56 ImQuest 56 Mary Tagliaferri 56 Patrick J. Balthrop 56 Pierre Cassigneul president 56 Tarvacin TM 56 Camillo Ricordi MD 56 GRNVAC1 56 HPCGG 56 SinuNase ™ 56 Jacob Inbar 56 Wolfgang Renner 56 Tom van Aken 56 Safi Bahcall Ph.D. 56 ImmuneRegen BioSciences Inc. 56 Lentigen 56 Ocular Therapeutix 56 Vaccine Adjuvant 56 Aegera 56 non nucleoside inhibitor 56 sorafenib Nexavar 56 ORWH 56 Archexin 56 Panzem R NCD 56 JAK2 Inhibitor 56 Biodesix 56 ConjuGon 56 Loïc Maurel MD 56 Craig Tuttle Transgenomic 56 Phase 2b Trial 56 Teriflunomide 56 InteKrin Therapeutics 56 C3 Jian 56 Richard DiMarchi 56 HTS assay 56 Anker MD Ph.D. 56 UPLYSO 56 Phytomedics Inc. 56 InteKrin 56 vidofludimus 56 PEG SN# 56 JAK2 inhibitor 56 targeted antifolate 56 Christopher J. Schaber 56 Hakon Hakonarson 56 HGS# 56 beta 1a 56 PF # [002] 56 Christopher Anzalone Arrowhead 56 depsipeptide 56 Cylene Pharmaceuticals 56 Artificial Pancreas Project 56 AIR2 Trial 56 uricase 56 aTyr Pharma 56 Phase 2b Clinical Trial 56 Steven A. Kriegsman 56 Oxxon 56 Kauffman MD Ph.D. 56 Manja Bouman CEO 56 BN ImmunoTherapeutics 56 Murray Tekmira 56 immunotherapeutic vaccine 56 Potelligent Technology 56 novel peptides 56 J. Donald deBethizy 56 ZFP Therapeutics 56 Joel Kupersmith 56 initiated Phase Ib 56 CAMPATH 56 Prolexys 56 Harold H. Shlevin 56 Cara Therapeutics 56 OvaRex R 55 AviaraDx 55 Tumor Microenvironment 55 VARI Laboratory 55 PNT# 55 EGEN 55 Adrian Hobden 55 Curemark 55 Aplidin 55 NKT Therapeutics 55 Virulizin ® 55 André Michel Ballester 55 Dr. Gussak 55 Lonnie Moulder 55 SNS# T 55 Kenneth I. Moch 55 Prof. Desire Collen 55 Bayer HealthCare Onyx Pharmaceuticals 55 Steven R. Deitcher 55 Panacea Pharmaceuticals 55 Darinaparsin 55 WRAIR 55 Ele Ferrannini 55 Alinia 55 Panzem NCD 55 Translational Biology 55 Prabhavathi Fernandes Ph.D. 55 Martin Moskovits 55 HQK 55 BioSET 55 Chang Ahn Rexahn 55 Yves Rosconi 55 Burkhard Phone 55 Dr. Fehlings 55 oncolytic virus therapies 55 Cellerant 55 indibulin 55 William Moffitt Nanosphere 55 Viral Immunotherapy platform 55 humanised monoclonal antibody 55 Pablo Legorreta Chief Executive 55 Patrick Fourteau 55 Dr. Yusibov 55 Dr. Siva Sivananthan 55 Septin9 biomarker 55 miRagen 55 ACLARA 55 commented Mitchel Sayare 55 OMP #M# 55 Dr. Sosne 55 Anna Gluskin Generex 55 Dr. Weidong Yin 55 Bruce Galton 55 FASgen 55 PDE4 inhibitor 55 Initiate Phase 55 Eric Van Cutsem 55 Yaffa Beck 55 Fc fusion protein 55 Francois Nader 55 Scott Pancoast Lpath 55 Quark Pharmaceuticals 55 Power3 Medical 55 Vaccinex 55 Quanterix 55 Robin Stracey 55 thetreatment 55 Capsulution 55 Hakan Edstrom 55 MD Ph.D. Kosan 55 OHR/AVR# 55 Novel Antibody 55 CA4P 55 Xcytrin R 55 Affibody 55 Caris MPI 55 Carl LeBel 55 ALN TTR 55 ELACYT 55 Nautilus Biotech 55 FOLOTYN ® 55 Michael Egholm 55 Rik J Deitsch 55 novel immunotherapies 55 CCR9 antagonist 55 Somesh Sharma 55 Ellen Vitetta 55 Genaera Corporation 55 Regado Biosciences 55 ganetespib 55 Michele Garufi Chairman 55 Can Fite 55 drug GAP #B# 55 LigoCyte 55 AMEX RGN 55 Mpex 55 Source MDx 55 Dr. Ellen Vitetta 55 Nanotherapeutics 55 Factor VIIa 55 Therinject 55 Angiolix 55 Dietrich Stephan 55 Michael Kishbauch 55 INCB# [001] 55 GlycoMimetics 55 GRN# 55 PhaseBio 55 HemoShear 55 Awarded Qualifying Therapeutic 55 commented Nicholas Landekic 55 PNP inhibitor 55 PhD DSc 55 Nanobiotix 55 Velcura Therapeutics 55 Steve Worland Ph.D. 55 Arno Therapeutics 55 Agios Pharmaceuticals 55 HDL Mimetic Peptide 55 Tezampanel 55 Kinase Inhibitor 55 Fred Eshelman PPD 55 AEG# 55 Galenea 55 Dr. Kobi Vortman 55 Dr. Steven Tsengas 55 Cardiovascular Therapeutics 55 Nanotechnology Characterization Laboratory 55 Vivecon 55 See CLINICAL PHARMACOLOGY 55 Immune Tolerance Network 55 Micromet BiTE 55 Semafore Pharmaceuticals 55 Theranostics 55 trastuzumab DM1 T DM1 55 Sapacitabine 55 Tikvah Therapeutics 55 Robert J. Broeze 55 Martin Nicklasson 55 polycythemia vera essential thrombocythemia 55 Vandetanib 55 Presents Preclinical Data 55 NEUGENE antisense 55 Phase Ib study 55 Integral Molecular 55 highly selective inhibitor 55 Jim Musick Vitro 55 Thomas Ichim 55 Therion Biologics Corporation 55 Cempra 55 HuMax 55 REGiMMUNE 55 Postdoctoral Position 55 vivo preclinical 55 Stephen M. Simes 55 Roche Molecular Diagnostics 55 siRNA therapeutics 55 Jens Schneider Mergener 54 A3 adenosine receptor 54 huC# DM4 54 XenoTech 54 IRX Therapeutics 54 Excelimmune 54 Amorcyte 54 Trubion Pharma 54 Neurome 54 pralatrexate injection folate analogue 54 Successfully Completes Phase 54 DiaKine Therapeutics 54 demonstrated antitumor activity 54 Taligen Therapeutics 54 KL4 Surfactant 54 ANAVEX 54 Humacyte 54 EVGN 54 ARRY # 54 Valopicitabine 54 acetonide FA 54 John Langstaff Cangene 54 Receptos 54 Receives Orphan Drug 54 Vaughn M. Kailian 54 TOPIGEN 54 Selecta Biosciences 54 Allovectin 7 ® 54 Personalized Immunotherapy 54 EDRN 54 BioRexis 54 Anavex #-# 54 MacuSight 54 Haro Hartounian 54 Revotar 54 Dr. Stylli 54 Alder Biopharmaceuticals 54 Drew Fromkin President 54 Daniel M. Skovronsky 54 Edward M. Rudnic 54 Arete Therapeutics 54 SYN# 54 Joseph K. Belanoff 54 Adult Stem Cell Therapy 54 commented Alexis Borisy 54 ProImmune 54 Viamet 54 multi kinase inhibitor 54 Naglazyme R 54 NS5B polymerase 54 TTF Therapy 54 Initiates Clinical Trial 54 TLR9 agonist 54 Shows Promise Against 54 Protexia ® 54 NIBIB 54 anticoagulant reversing agent 54 translational genomics 54 mertansine 54 DiaKine 54 NEUGENE R 54 sorafenib tablets 54 Myocet 54 cytokine refractory 54 antisense inhibitors 54 Daclizumab 54 PSMA ADC 54 RhuDex ® 54 Hem Pandya 54 Juvaris BioTherapeutics 54 tubulin inhibitor 54 George W. LeMaitre 54 Symphogen 54 Scil Proteins 54 PANVAC VF 54 Deborah Rathjen 54 Epitomics 54 Erinn B. Broshko 54 Jay Lichter 54 Adrian Hobden Ph.D. 54 Small Molecule 54 Dr. Daniel Zurr 54 Cenomed 54 YONDELIS 54 Neotropix 54 ASONEP 54 Poordad 54 Zeb Horowitz 54 platform HDL Mimetic 54 Raven Biotechnologies 54 ospemifene 54 HCD# [002] 54 Jan Turek Biolex 54 IAP inhibitor 54 OMNARIS HFA 54 PHX# 54 Polyphor 54 LymphoStat B TM 54 TELINTRA R 54 Pressure BioSciences 54 ChemBridge Corporation 54 Bone Biologics 54 Orqis Medical 54 novel histone deacetylase 54 Dr. Von Hoff 54 antibody MAb 54 PARI Pharma 54 Pedro Lichtinger Optimer 54 Dr. Bernhard Sixt 54 Evoltra ® 54 Ph.D. D.Sc. 54 Begins Dosing 54 QIAGEN GmbH 54 Deforolimus 54 oral prodrug 54 iCardiac Technologies 54 Sylvain Fleury 54 Bernd Seizinger 54 Galakatos 54 Jay Kolls 54 Innate Therapeutics 54 Molecular Genetics Laboratory 54 selective kinase inhibitor 54 Thiarabine 54 novel VDA molecule 54 NicOx commented 54 vitro pharmacology 54 Locus Pharmaceuticals 54 Derek Hennecke 54 TapImmune 54 eniluracil 54 Fludara ® 54 Ulrich Grau Ph.D. 54 Hybridon 54 CRMD# 54 KAI Pharmaceuticals 54 LEAD Therapeutics 54 Novel Therapeutic 54 Lorianne Masuoka MD 54 Wadih Arap 54 Erkki Ruoslahti 54 Lennart Mucke 54 Johns Hopkins Sidney Kimmel 54 oral JAK1 54 Quark Biotech Inc. 54 CancerGuide 54 Talabostat 54 Stan Yakatan 54 Xencor 54 Dr. Vitetta 54 Arthur S. Przybyl 54 Carl A. Pelzel 54 Dr. Dov Tamarkin 54 Teplizumab 54 Biochemical Genetics 54 ASU Biodesign Institute 54 Velcura 54 Biomodels 54 plasmid DNA vaccine 54 Quark Biotech 54 Fresenius Biotech 54 Steve Cartt Executive 54 Professor Silviu Itescu 54 Veronate R 54 Martyn Coombs 54 CGEN # 54 oral dihydropyrimidine dehydrogenase DPD 54 Antigen Specific 54 ImmuneRegen BioSciences 54 Klaus Schollmeier 54 R. Luber 54 potent suppressor 54 Ronald Brus 54 Cethromycin 54 oncolytic virus 54 Interferon alpha 54 rxRNA 53 CorMatrix 53 NIH NIAID 53 serogroup B 53 histone deacetylase HDAC inhibitor 53 BioVant 53 anti CD3 monoclonal 53 HemaQuest 53 Nereus Pharmaceuticals 53 Wolf Reik 53 Zymeworks 53 Eran Broshy 53 Hoyoung Huh MD Ph.D. 53 Arthur Bedrosian president 53 Hsp# Inhibitor 53 Bioheart Inc. 53 Virosome Biologicals 53 defensin mimetic antibiotic 53 Amar Sawhney 53 Antibody Drug Conjugate 53 Cancer Immunotherapeutics 53 RainStorm 53 NV1FGF 53 Proacta 53 please visit www.metabolon.com 53 Dan Passeri 53 Ophthotech 53 Preclinical Study 53 FoldRx 53 FDA CDER 53 Civacir 53 William Freytag 53 PsychoGenics 53 Dr. Frank DiCosmo 53 RhuDex 53 IMA# 53 essential thrombocythemia ET 53 Charles Homcy MD 53 stated Barry Polisky 53 Optimata 53 Jaap Goudsmit 53 Ostarine ™ 53 CDDO Im 53 Alzhemed TM 53 Tobinick 53 Timo Veromaa 53 Vaxfectin R formulated 53 PEGylated 53 EnVivo Pharmaceuticals Inc. 53 DermaVir 53 vaccinology 53 Carfilzomib 53 Microbiology Immunology 53 ALN VSP Phase 53 Mark P. Colonnese 53 CompoZr 53 Sequella 53 Schall Ph.D. 53 nanoviricides 53 Carl Pelzel Depomed 53 Daniel Passeri Curis 53 Neugene 53 Clive Svendsen 53 receptor inhibiting monoclonal 53 R#/MEM # 53 tramiprosate Alzhemed TM 53 Adenosine Therapeutics 53 Intrinsic Bioprobes 53 Dr. Alessio Fasano 53 Andre Terzic 53 Thomas Südhof 53 OSUCCC 53 AAG geldanamycin analog 53 Mymetics 53 Syncria 53 LB# [003] 53 AmpliMed 53 Sagar Lonial MD 53 proteasome inhibitor 53 Sirion Therapeutics 53 Stem Cell Innovations 53 Syntaxin 53 Cathepsin S 53 Cellular Immunology 53 Igor Gonda 53 BellBrook Labs 53 Metastatix 53 Response Genetics 53 WILEX AG 53 Robert D. Battis 53 simplex virus 53 Joseph Loscalzo 53 vapreotide acetate 53 Pedro Lichtinger 53 DepoVax 53 Ms. Gerri Henwood 53 Strauss Noven 53 trastuzumab Herceptin R 53 Attitude Drinks Inc. 53 selective inhibition 53 KineMed 53 Xelox 53 Cellular Therapy 53 Yuichi Iwaki MD Ph.D. 53 Anders Essen Moller 53 Daniel O. Wilds 53 sitaxsentan 53 Osmetech plc 53 Sopherion 53 MolecularMD 53 BioGeneriX 53 Clay Siegall 53 Dr. Pasinetti 53 ZyStor Therapeutics Inc. 53 StemEx R 53 Isotechnika Pharma 53 Charis Eng 53 Myoblast Program 53 Preclinical Models 53 Panzem 53 Fabry Disease 53 tkRNAi 53 ACE BioSciences 53 therapeutic monoclonal antibodies 53 Campath alemtuzumab 53 adult mesenchymal stem 53 xenograft models 53 pharmacogenomic translational research 53 IDRI 53 Phase Ib II 53 PRTX 53 Biocept 53 Cancer Immunotherapy 53 Ozarelix 53 Hydra Biosciences 53 ERYtech Pharma 53 Dr. Henrich Guntermann 53 Cellerant Therapeutics 53 Expands Scientific Advisory 53 including eniluracil ADH 53 Idera Pharmaceuticals 53 Emil Kakkis MD Ph.D. 53 candidate deforolimus 53 Dr. Laszlo Urge 53 Cerimon Pharmaceuticals 53 VisEn Medical 53 Richard Garr Neuralstem 53 Degarelix 53 OvaRex MAb 53 Resolvyx Pharmaceuticals 53 Functional Genetics 53 Phase 1b trial 53 Edward H. Bersoff 53 Christian Homsy 53 Gary Nabel MD 53 Mr. Ellberger 53 Pepscan 53 Gail Maderis 53 Xanafide 53 OHRI 53 Bexion 53 CTAP# Capsules 53 Genisphere 53 Vincent Milano ViroPharma 53 glucokinase activator 53 Phase IIb Clinical Trial 53 Jim DeMesa 53 Phase #/#a trial 53 Actilon 53 AGY Therapeutics 53 Inc. Nasdaq IMGN 53 NABTT 53 deCODE chemistry 53 Imprime PGG 53 Expression Pathology 53 initiated Phase 1b 53 Singulex 53 murine monoclonal antibody 53 virosome 53 Samuel Stupp 53 epigenetic therapies 53 Joseph Feczko 53 RhuDex TM 53 Ridaforolimus 53 IMiDs ® 53 Genocea Biosciences 53 radezolid 53 stated Dominique Costantini 53 Kyto 53 Cheminformatics 53 eTag assays 53 enzymology 53 Roch Doliveux Chief Executive 53 Sabine Bahn 53 Phase III Pivotal 53 Daniel Tasse 53 Dr. Dinarello 53 phase Ib 53 agonistic human 53 phosphatidylserine PS targeting 53 Gregory D. Casciaro 53 AcuFocus 53 Anna Gluskin 53 Nickolas Papadopoulos 53 Sc.M. 53 Jörn Aldag President 53 Cardioxyl Pharmaceuticals 53 Harold Varmus MD 53 Protalex Inc. 53 Omthera 53 John A. Kraeutler 53 Ceflatonin R 53 Dr. Hassan Salari 53 Aerie Pharmaceuticals 53 Karolinska Institute Stockholm Sweden 53 Dr. Maraganore 53 Initiates Enrollment 53 Diamyd ® 53 TM Aganocide 53 small molecule thrombopoietin 53 Solazed 53 Oxford Genome Sciences 53 Catalyst Biosciences 53 Epitome Biosystems 53 Infectech 53 Otelixizumab 53 Commercialize Novel 53 dasatinib Sprycel 53 Monique MB Breteler 53 Files IND 53 Synageva 53 Rosetta Genomics microRNA 53 PrimeGen Biotech 53 Almac Diagnostics 53 Tarvacin 53 Gearoid Faherty Chief Executive 53 CMV vaccine 53 ERYtech 53 Transfection Reagent 53 Thomas Tuschl 53 ProtoKinetix 53 potent topoisomerase II 52 Pimavanserin 52 Antitope 52 TPI ASM8 52 ImaginAb 52 Lance Liotta 52 humanized therapeutic 52 Saegis Pharmaceuticals 52 vascular disrupting agents 52 Tapestry Pharmaceuticals 52 Genizon 52 Alan Colowick 52 HuMax CD# 52 Aushon BioSystems 52 Cytomegalovirus CMV 52 Charlesson 52 papillary renal cell carcinoma 52 TG# [003] 52 Novosom 52 targeted radiotherapeutic 52 Dr. Steve Pakola 52 Guy Malchi 52 ChemImage 52 Developmental Therapeutics Program 52 Sven Andreasson 52 TNFerade ™ 52 Group B CALGB 52 Romidepsin 52 Pacific Biomarkers 52 ESBATech AG 52 Dr. Declan Doogan 52 LEAPS TM 52 Tarvacin Anti Cancer 52 Hugues de Bantel 52 OncoVEX 52 PROSTVAC VF 52 Saneron 52 Matthew Emmens Chairman 52 Experimental Therapeutics 52 transgenic rats 52 Phase III ADT 52 DXL# 52 Aeolus Pharmaceuticals Announces 52 Brian Druker 52 immunobiology 52 Bioanalysis 52 Nancy Simonian 52 Arimoclomol 52 Evolva 52 nucleoside analog 52 Ronald Brus Crucell 52 JBEI 52 Integrated Preclinical 52 adenoviral vectors 52 MT# MEDI 52 NanoViricides 52 gemcitabine cisplatin 52 BioLeap 52 Expression Genetics 52 Vaxfectin 52 Elusys 52 Pieter Muntendam 52 El Deiry 52 InDevR 52 cathepsin K inhibitor 52 Litx 52 George Coukos 52 Dr. Kshitij Mohan 52 LymphoStat B belimumab 52 Amir Avniel President 52 Anticancer Agents 52 Carolyn Bertozzi 52 HepaLife 52 InNexus 52 Philippe Calais 52 Ocrelizumab 52 JNJ Q2 52 Dr Werner Lanthaler 52 Tyrosine Kinase Inhibitor 52 Belldegrun 52 Aerovance 52 systemically administered 52 Protexia R 52 Allovectin 7 R 52 Aestus